Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data

Read Time:6 Second

Structure’s pill is part of the same class of drugs as Novo Nordisk’s blockbuster diabetes drug Ozempic and weight loss counterpart Wegovy.

About Post Author

Happy

0 %

Sad

0 %

Excited

0 %

Sleepy

0 %

Angry

0 %

Surprise

0 %

It marked another increase after the prior month's annual gain of 6%, and the fastest rate of price growth since...

Walmart said clinics are not a sustainable business model due to a challenging reimbursement environment for primary care and increasing...

Zepbound reported $517.4 million in sales for the quarter, even as most doses of the drug slipped into shortages in...

One of the largest entertainment operators in the country, Dave & Buster's, will allow its loyalty customers to compete against...

The restaurant company is planning to spend $2.2 billion to revive Burger King's U.S. business.

The nation's largest grocer sees room to build on its inflation-fueled grocery gains.